Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Ryan Van Lieshout, Canada Research Chair in Perinatal Mental Health, McMaster University

Zuranolone for postpartum depression: Hope, hype or both?

While zuranolone represents an exciting advance in the treatment of postpartum depression, many questions about its potential impact remain unanswered. (Shutterstock)

While mothers with postpartum depression have always faced barriers accessing the care they need, things have been particularly bad since the onset of the COVID-19 pandemic.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.